Edgen Stock·Dec 16 2025, 00:07返回
吉利德艾滋病药物在3期临床试验中取得成功
Edgen Stock·Dec 16 2025, 00:07
[1] 减肥药临床试验显示平均体重减轻30% - 药学杂志 (https://pharmaceutical-journal.com/article/ne ...)[2] Argenyx的Vyvgart在甲状腺眼病三期试验中失败，增加正在进行的试验风险 - BioSpace (https://www.biospace.com/drug-development/arg ...)[3] Immunome凭借Desmoid肿瘤药物在三期扫描后前往FDA - BioSpace (https://www.biospace.com/drug-development/imm ...)
